These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25805513)

  • 1. New analysis tools for observational studies.
    Landewé RB
    Z Rheumatol; 2015 Mar; 74(2):113-8. PubMed ID: 25805513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [From uncertainty to evidence : modern statistics in rheumatology].
    Zink A; Sieper J
    Z Rheumatol; 2015 Mar; 74(2):104-5. PubMed ID: 25805511
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of statisticians in epidemiological research].
    Schlittgen R
    Z Rheumatol; 2015 Mar; 74(2):132-6. PubMed ID: 25805516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modern study designs and analysis methods in clinical research].
    Gerß J; Eveslage M; Faldum A; Schmidt R
    Z Rheumatol; 2015 Mar; 74(2):106-12. PubMed ID: 25805512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology.
    Wolfe F; Lassere M; van der Heijde D; Stucki G; Suarez-Almazor M; Pincus T; Eberhardt K; Kvien TK; Symmons D; Silman A; van Riel P; Tugwell P; Boers M
    J Rheumatol; 1999 Feb; 26(2):484-9. PubMed ID: 9972992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point and interval estimation of baseline risk and treatment effect based on logistic model for observational studies.
    Wang X; Yin L
    Biom J; 2015 May; 57(3):441-52. PubMed ID: 25810034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods to analyze real-world databases and registries.
    Kremers HM
    Bull NYU Hosp Jt Dis; 2009; 67(2):193-7. PubMed ID: 19583553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The OMERACT filter for Outcome Measures in Rheumatology.
    Boers M; Brooks P; Strand CV; Tugwell P
    J Rheumatol; 1998 Feb; 25(2):198-9. PubMed ID: 9489805
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment outcome parameters].
    Burmester GR; Smolen J
    Z Rheumatol; 2009 Feb; 68(1):9. PubMed ID: 19156433
    [No Abstract]   [Full Text] [Related]  

  • 11. Methods for analyzing observational longitudinal prognosis studies for rheumatic diseases: a review & worked example using a clinic-based cohort of juvenile dermatomyositis patients.
    Lim LS; Pullenayegum E; Moineddin R; Gladman DD; Silverman ED; Feldman BM
    Pediatr Rheumatol Online J; 2017 Mar; 15(1):18. PubMed ID: 28356102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A brief introduction to the National Data Bank for Rheumatic Diseases.
    Wolfe F; Michaud K
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S168-71. PubMed ID: 16273802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-Varying Treatments in Observational Studies: Marginal Structural Models of the Effects of Early Grade Retention on Math Achievement.
    Vandecandelaere M; Vansteelandt S; De Fraine B; Van Damme J
    Multivariate Behav Res; 2016; 51(6):843-864. PubMed ID: 27093501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causal inference from experiment and observation.
    Zwahlen M; Salanti G
    Evid Based Ment Health; 2018 Feb; 21(1):34-38. PubMed ID: 29289944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II.
    Cox E; Martin BC; Van Staa T; Garbe E; Siebert U; Johnson ML
    Value Health; 2009; 12(8):1053-61. PubMed ID: 19744292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cross-cut statistic and its sensitivity to bias in observational studies with ordered doses of treatment.
    Rosenbaum PR
    Biometrics; 2016 Mar; 72(1):175-83. PubMed ID: 26295693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal studies in rheumatology: some guidance for analysis.
    Lesaffre E
    Bull NYU Hosp Jt Dis; 2012; 70(2):65-72. PubMed ID: 22891996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rheumatology-specific informatics-based application with a disease activity calculator.
    Collier DS; Kay J; Estey G; Surrao D; Chueh HC; Grant RW
    Arthritis Rheum; 2009 Apr; 61(4):488-94. PubMed ID: 19333976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What has been the effect on trial outcome assessments of a decade of patient participation in OMERACT?
    de Wit MP; Abma TA; Koelewijn-van Loon MS; Collins S; Kirwan J
    J Rheumatol; 2014 Jan; 41(1):177-84. PubMed ID: 24128777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observational research in rheumatic disorders.
    Choi HK; Seeger JD
    Rheum Dis Clin North Am; 2004 Nov; 30(4):685-99, v. PubMed ID: 15488688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.